New Pediatric Clinical Research Study Enrolling
Update: As of 3.20.19, this pediatric hyperhidrosis clinical trial has been filled.
I’m excited to share with you an important clinical study that is now recruiting pediatric patients with axillary (underarm) hyperhidrosis. Enrollment for this study closes soon, so don’t wait to get your child involved!
The BBI-4000-CL-105 Study
This is a nationwide hyperhidrosis study for pediatric patients who are:
Ages nine through less than 17 years of age
Are male or female
Have had sweaty underarms (axillary hyperhidrosis) for at least six months
What Is This Sweat Study For?
This nationwide pediatric research study is investigating a potential new treatment for axillary hyperhidrosis.
Important Things to Know
- This is an outpatient study (meaning you will not need to stay overnight at the doctor’s office) and is performed at a dermatologist’s clinic.
- The duration of the study will be 21 days with five scheduled office visits.
- Compensation to you for completing these visits is available.
- Patients successfully completing the BBI-4000-CL-105 study are eligible for a six month follow-up safety study (BBI-4000-CL-108) which will involve up to an additional six months of study participation and requires monthly visits.
How to Participate in This Pediatric Hyperhidrosis Study
Visit bbi4000cl105.com and fill out the form to be contacted about participating in this hyperhidrosis clinical trial. Your information will be kept secure and not added to any mailing lists.
Disclosure: This is a sponsored post in collaboration with Brickell Biotech, Inc.
and is IRB approved.
